Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
15M
-
Shares change
-
+656K
-
Total reported value, excl. options
-
$284M
-
Value change
-
-$13.7K
-
Number of buys
-
49
-
Number of sells
-
-9
-
Price
-
$19.01
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q4 2019
65 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q4 2019.
TransMedics Group, Inc. - Common Stock (TMDX) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15M shares
of 33.9M outstanding shares and own 44.07% of the company stock.
Largest 10 shareholders include ABRAMS CAPITAL MANAGEMENT, L.P. (3.5M shares), FMR LLC (3.17M shares), CREDIT SUISSE AG/ (1.13M shares), BlackRock Inc. (858K shares), Sandhill Capital Partners LLC (736K shares), VANGUARD GROUP INC (654K shares), PRICE T ROWE ASSOCIATES INC /MD/ (522K shares), RTW INVESTMENTS, LP (503K shares), Zimmer Partners, LP (491K shares), and EMERALD ADVISERS, LLC (452K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.